Boehringer launches at long-end of Schuldschein mart

Boehringer Ingelheim, the German pharmaceutical group, has decided to tap the long end of the Schuldschein market by launching a 10 year deal. The note is understood to be the first of that tenor in 2009 and is clear sign of the market’s recovery, according to bankers.

  • 11 Jun 2009

Boehringer, which is unrated but considered to be a double-A credit, launched its Eu300m five, seven and ten year facility towards the end of last week. Respective guidance on the tranches is 190bp-215bp, 235bp-260bp and 280bp-310bp.

The deal is being led by Helaba, HSBC and LBBW.

Bankers in Germany said ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 BNP Paribas 10,542 20 17.55
2 Bank of America Merrill Lynch (BAML) 6,103 21 10.16
3 Citi 5,130 13 8.54
4 JP Morgan 4,681 6 7.79
5 Morgan Stanley 4,137 11 6.89

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 81,261.11 236 11.54%
2 Bank of America Merrill Lynch 66,433.81 187 9.43%
3 Wells Fargo Securities 57,637.40 170 8.18%
4 JPMorgan 53,570.42 158 7.61%
5 Credit Suisse 45,349.30 117 6.44%